Perspectives on n-3 PUFAs: Primary prevention, antiarrhythmic effects, congestive heart failure

European Heart Journal, Supplement

Volumn 3, Issue SUPPL.4, 2001, Pages

  Maggioni, A P ^a   Tavazzi, L ^b   Marchioli, R ^c   Tognoni, G ^d   Avanzini, F ^e   Roncaglioni, M C ^d  

^a ANMCO RESEARCH CENTER   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c Consorzio Mario Negri Sud ^*  (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e UOC Anestesia e Rianimazione   (Italy)

Author keywords

Arrhythmias; Congestive heart failure; n 3 PUFA; Primary prevention

Indexed keywords

EID: 0008879281     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(01)90128-2     Document Type: Review

References (9)

1. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447-55.
2. Chambless L, Keil U, Dobson A et al. Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Circulation 1997; 96: 3849-59.
3. Packer M, Bristow MR, Cohn JN et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-55.
4. CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353: 9-13.
5. MERIT-HF Study Group. Effects of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure. (MERIT-HF). J Am Med Assoc 2000; 283: 1295-302.
6. Zannad PB, Remme WJ, Cody R et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 1999; 341: 709-17.
7. Collaborative Group of the Primary Prevention Project (PPP). Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 2001; 357: 89-95.
8. Opasich C, Tavazzi L, Lucci D et al. Comparison of one-year outcome in women versus men with chronic congestive heart failure. Am J Cardiol 2000; 86: 353-7.
9. Marchioli R, Avanzini A, Barzi F et al. on behalf of GISSI-Prevenzione Investigators. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factors assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J 2001 (in press).